Navigation Links
Reportlinker Adds Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Date:5/24/2011

NEW YORK, May 24, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

http://www.reportlinker.com/p0511072/Drug-Delivery-Devices-Market-Outlook-in-China-to-2017---Metered-Dose-Inhaler-Devices-Infusion-Systems-Central-Venous-Catheters-and-Needle-Free-Injections.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Summary

GlobalData's new report, "Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections" provides key market data on the China Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the four market categories.

- Global corporate-level profiles of key companies operating within the China Drug Delivery Devices market.

- Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Sunovion, Fresenius Kabi AG, 3M Health Care and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the China Drug Delivery Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 9

2 Introduction 11

2.1 What is This Report About? 11

3 Drug Delivery Devices In China 12

3.1 Drug Delivery Devices, Market Segmentation 12

3.2 Drug Delivery Devices, China, Overall Revenue ($m), 2003-2017 13

3.3 Drug Delivery Devices Market, China, Revenue Mix ($m), 2010 15

3.4 Drug Delivery Devices Market, China, Category Contribution (%), 2010 16

3.5 Drug Delivery Devices, China, Category Volume (Units), 2003-2017 22

3.6 Drug Delivery Devices, China, Company Share (2009-2010) 27

4 Central Venous Catheters In China 29

4.1 Central Venous Catheters, Market Segmentation 29

4.2 Central Venous Catheters Market, China, Revenue Mix ($m), 2010 30

4.3 Central Venous Catheters Market, China, Segment Contribution (%), 2010 31

4.4 Central Venous Catheters Overall Revenue (2003-2017) 32

4.5 Central Venous Catheters Overall Volume (2003-2017) 36

4.6 Central Venous Catheters Average Price (2003-2017) 39

4.7 Central Venous Catheters Distribution Share (2009-2010) 40

4.8 Central Venous Catheters, China, Company Share (2009-2010) 41

5 Infusion Systems In China 43

5.1 Infusion Systems, Market Segmentation 43

5.2 Infusion Systems Market, China, Revenue Mix ($m), 2010 44

5.3 Infusion Systems Market, China, Segment Contribution (%), 2010 45

5.4 Infusion Systems Overall Revenue (2003-2017) 46

5.4.1 Syringe Pumps Revenue (2003-2017) 50

5.4.2 Ambulatory Infusion Pumps Revenue (2003-2017) 54

5.5 Infusion Systems Overall Volume (2003-2017) 58

5.5.1 Syringe Pumps Volume (2003-2017) 62

5.5.2 Ambulatory Infusion Pumps Volume (2003-2017) 65

5.6 Infusion Systems Average Price (2003-2017) 69

5.7 Infusion Systems Distribution Share (2009-2010) 70

5.8 Infusion Systems, China, Company Share (2009-2010) 71

6 Metered Dose Inhaler Devices In China 73

6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 73

6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 75

6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 77

6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 78

6.5 Metered Dose Inhaler Devices, China, Company Share (2009-2010) 79

7 Needle Free Injections In China 81

7.1 Needle Free Injections Overall Revenue (2003-2017) 81

7.2 Needle Free Injections Overall Volume (2003-2017) 83

7.3 Needle Free Injections Average Price (2003-2017) 85

7.4 Needle Free Injections Distribution Share (2009-2010) 86

7.5 Needle Free Injections, China, Company Share (2009-2010) 87

8 Overview of Key Companies in China Drug Delivery Devices Market 88

8.1 GlaxoSmithKline plc 88

8.1.1 Company Overview 88

8.1.2 Share in the China Drug Delivery Devices Market 88

8.2 AstraZeneca PLC 89

8.2.1 Company Overview 89

8.2.2 Share in the China Drug Delivery Devices Market 89

8.3 Boehringer Ingelheim GmbH 90

8.3.1 Company Overview 90

8.3.2 Share in the China Drug Delivery Devices Market 90

8.4 Sunovion 91

8.4.1 Share in the China Drug Delivery Devices Market 91

8.5 Fresenius Kabi AG 92

8.5.1 Company Overview 92

8.5.2 Share in the China Drug Delivery Devices Market 92

8.6 3M Health Care 93

8.6.1 Company Overview 93

8.7 Baxter International Inc. 93

8.7.1 Company Overview 93

8.8 Terumo Corporation 93

8.8.1 Company Overview 93

8.9 Teleflex Incorporated 94

8.9.1 Company Overview 94

8.10 Hospira, Inc. 94

8.10.1 Company Overview 94

8.11 Medtronic, Inc. 95

8.11.1 Company Overview 95

8.12 Consort Medical plc 95

8.12.1 Company Overview 95

8.13 Smiths Medical 95

8.13.1 Company Overview 95

8.14 JMS CO., LTD. 96

8.14.1 Company Overview 96

8.15 CareFusion Corporation 96

8.15.1 Company Overview 96

8.16 NIPRO CORPORATION 97

8.16.1 Company Overview 97

8.17 B. Braun Melsungen AG 97

8.17.1 Company Overview 97

8.18 Edwards Lifesciences Corporation 97

8.18.1 Company Overview 97

8.19 INJEX - Equidyne Systems 98

8.19.1 Company Overview 98

8.20 Bioject Medical Technologies Inc. 98

8.20.1 Company Overview 98

9 Drug Delivery Devices Market Pipeline Products 99

10 Financial Deals Landscape 104

10.1 Acquisition 104

10.1.1 Mindray Medical International to Acquire Controlling Stake in Shenzhen Shenke Medical Instrument 104

10.2 Partnerships 105

10.2.1 Bayer Schering Pharma Enters Into An Agreement With National Pharmaceutical Engineering Research Center 105

11 Appendix 106

11.1 Definitions of Markets Covered in the Report 107

11.1.1 Drug Delivery Devices 107

11.2 Research Methodology 110

11.3 Secondary Research 110

11.4 Primary Research 111

11.5 Models 111

11.6 Forecasts 112

11.7 Expert Panels 112

11.8 GlobalData Consulting 112

11.9 Currency Conversion 112

11.10 Contact Us 113

11.11 Disclaimer 113

1.1 List of Tables

Table 1: Drug Delivery Devices, China, Overall Revenue ($m), 2003-2017 14

Table 2: Drug Delivery Devices Market, China, Category Contribution (%), 2010 16

Table 3: Drug Delivery Devices, China Cross-Category Analysis, 2003-2017 17

Table 4: Drug Delivery Devices, China, Overall Revenue ($m), Historic, 2003-2010 19

Table 5: Drug Delivery Devices, China, Overall Revenue ($m), Forecast, 2010-2017 21

Table 6: Drug Delivery Devices, China, Category Volume (Units), 2003-2017 22

Table 7: Drug Delivery Devices, China, Category Volume (Units), Historic, 2003-2010 24

Table 8: Drug Delivery Devices, China, Category Volume (Units), Forecast, 2010-2017 26

Table 9: Drug Delivery Devices, China, Company Share by Revenue ($m), 2009-2010 28

Table 10: Central Venous Catheters Market, China, Segment Contribution (%), 2010 31

Table 11: Central Venous Catheters, China, Revenue ($m) by Segment, Historic, 2003-2010 33

Table 12: Central Venous Catheters, China, Revenue ($m) by Segment, Forecast, 2010-2017 35

Table 13: Central Venous Catheters, China, Volume (Units) by Segment, Historic, 2003-2010 37

Table 14: Central Venous Catheters, China, Volume (Units) by Segment, Forecast, 2010-2017 38

Table 15: Central Venous Catheters, China, Average Price ($), Historic, 2003-2010 39

Table 16: Central Venous Catheters, China, Average Price ($), Forecast, 2010-2017 39

Table 17: Central Venous Catheters, China, Distribution Share by Revenue ($m), 2009-2010 40

Table 18: Central Venous Catheters, China, Company Share by Revenue ($m), 2009-2010 42

Table 19: Infusion Systems Market, China, Segment Contribution (%), 2010 45

Table 20: Infusion Systems, China, Revenue ($m) by Segment, Historic, 2003-2010 47

Table 21: Infusion Systems, China, Revenue ($m) by Segment, Forecast, 2010-2017 49

Table 22: Syringe Pumps, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 51

Table 23: Syringe Pumps, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 53

Table 24: Ambulatory Infusion Pumps, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 55

Table 25: Ambulatory Infusion Pumps, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 57

Table 26: Infusion Systems, China, Volume (Units) by Segment, Historic, 2003-2010 59

Table 27: Infusion Systems, China, Volume (Units) by Segment, Forecast, 2010-2017 61

Table 28: Syringe Pumps, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 63

Table 29: Syringe Pumps, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 64

Table 30: Ambulatory Infusion Pumps, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 66

Table 31: Ambulatory Infusion Pumps, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68

Table 32: Infusion Systems, China, Average Price ($), Historic, 2003-2010 69

Table 33: Infusion Systems, China, Average Price ($), Forecast, 2010-2017 69

Table 34: Infusion Systems, China, Distribution Share by Revenue ($m), 2009-2010 70

Table 35: Infusion Systems, China, Company Share by Revenue ($m), 2009-2010 72

Table 36: Metered Dose Inhaler Devices, China, Revenue ($m), Historic, 2003-2010 73

Table 37: Metered Dose Inhaler Devices, China, Revenue ($m), Forecast, 2010-2017 74

Table 38: Metered Dose Inhaler Devices, China, Volume (Units), Historic, 2003-2010 75

Table 39: Metered Dose Inhaler Devices, China, Volume (Units), Forecast, 2010-2017 76

Table 40: Metered Dose Inhaler Devices, China, Average Price ($), Historic, 2003-2010 77

Table 41: Metered Dose Inhaler Devices, China, Average Price ($), Forecast, 2010-2017 77

Table 42: Metered Dose Inhaler Devices, China, Distribution Share by Revenue ($m), 2009-2010 78

Table 43: Metered Dose Inhaler Devices, China, Company Share by Revenue ($m), 2009-2010 80

Table 44: Needle Free Injections, China, Revenue ($m), Historic, 2003-2010 81

Table 45: Needle Free Injections, China, Revenue ($m), Forecast, 2010-2017 82

Table 46: Needle Free Injections, China, Volume (Units), Historic, 2003-2010 83

Table 47: Needle Free Injections, China, Volume (Units), Forecast, 2010-2017 84

Table 48: Needle Free Injections, China, Average Price ($), Historic, 2003-2010 85

Table 49: Needle Free Injections, China, Average Price ($), Forecast, 2010-2017 85

Table 50: Needle Free Injections, China, Distribution Share by Revenue ($m), 2009-2010 86

Table 51: Needle Free Injections, China, Company Share by Revenue ($m), 2009-2010 87

Table 52: Drug Delivery Devices Market Pipeline Products 99

Table 53: Mindray Medical International To Acquire Controlling Stake In Shenzhen Shenke Medical Instrument 104

Table 54: Bayer Schering Pharma Enters Into An Agreement With National Pharmaceutical Engineering Research Center 105

Table 55: USD to Local Currency, China, Average Actual Rate 2003-2010 112

1.2 List of Figures

Figure 1: Drug Delivery Devices, Market Segmentation 12

Figure 2: Drug Delivery Devices, China, Overall Revenue ($m), 2003-2017 13

Figure 3: Drug Delivery Devices Market, China, Revenue Mix ($m), 2010 15

Figure 4: Drug Delivery Devices Market, China, Category Contribution (%), 2010 16

Figure 5: Drug Delivery Devices, China, Cross-Category Analysis, 2003-2017 17

Figure 6: Drug Delivery Devices, China, Overall Revenue ($m), Historic, 2003-2010 18

Figure 7: Drug Delivery Devices, China, Overall Revenue ($m), Forecast, 2010-2017 20

Figure 8: Drug Delivery Devices, China, Category Volume (Units), 2003-2017 22

Figure 9: Drug Delivery Devices, China, Category Volume (Units), Historic, 2003-2010 23

Figure 10: Drug Delivery Devices, China, Category Volume (Units), Forecast, 2010-2017 25

Figure 11: Drug Delivery Devices, China, Company Share (%), 2010 27

Figure 12: Central Venous Catheters, Market Segmentation 29

Figure 13: Central Venous Catheters Market, China, Revenue Mix ($m), 2010 30

Figure 14: Central Venous Catheters Market, China, Segment Contribution (%), 2010 31

Figure 15: Central Venous Catheters, China, Revenue ($m) by Segment, Historic, 2003-2010 32

Figure 16: Central Venous Catheters, China, Revenue ($m) by Segment, Forecast, 2010-2017 34

Figure 17: Central Venous Catheters, China, Volume (Units) by Segment, Historic, 2003-2010 36

Figure 18: Central Venous Catheters, China, Volume (Units) by Segment, Forecast, 2010-2017 38

Figure 19: Central Venous Catheters, China, Company Share (%), 2010 41

Figure 20: Infusion Systems, Market Segmentation 43

Figure 21: Infusion Systems Market, China, Revenue Mix ($m), 2010 44

Figure 22: Infusion Systems Market, China, Segment Contribution (%), 2010 45

Figure 23: Infusion Systems, China, Revenue ($m) by Segment, Historic, 2003-2010 46

Figure 24: Infusion Systems, China, Revenue ($m) by Segment, Forecast, 2010-2017 48

Figure 25: Syringe Pumps, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 50

Figure 26: Syringe Pumps, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 52

Figure 27: Ambulatory Infusion Pumps, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 54

Figure 28: Ambulatory Infusion Pumps, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 56

Figure 29: Infusion Systems, China, Volume (Units) by Segment, Historic, 2003-2010 58

Figure 30: Infusion Systems, China, Volume (Units) by Segment, Forecast, 2010-2017 60

Figure 31: Syringe Pumps, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 62

Figure 32: Syringe Pumps, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 64

Figure 33: Ambulatory Infusion Pumps, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 65

Figure 34: Ambulatory Infusion Pumps, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 67

Figure 35: Infusion Systems, China, Company Share (%), 2010 71

Figure 36: Metered Dose Inhaler Devices, China, Revenue ($m), Historic, 2003-2010 73

Figure 37: Metered Dose Inhaler Devices, China, Revenue ($m), Forecast, 2010-2017 74

Figure 38: Metered Dose Inhaler Devices, China, Volume (Units), Historic, 2003-2010 75

Figure 39: Metered Dose Inhaler Devices, China, Volume (Units), Forecast, 2010-2017 76

Figure 40: Metered Dose Inhaler Devices, China, Company Share (%), 2010 79

Figure 41: Needle Free Injections, China, Revenue ($m), Historic, 2003-2010 81

Figure 42: Needle Free Injections, China, Revenue ($m), Forecast, 2010-2017 82

Figure 43: Needle Free Injections, China, Volume (Units), Historic, 2003-2010 83

Figure 44: Needle Free Injections, China, Volume (Units), Forecast, 2010-2017 84

Figure 45: Needle Free Injections, China, Company Share (%), 2010 87

Figure 46: GlaxoSmithKline plc, Company Share (%),China Drug Delivery Devices Market, 2010 88

Figure 47: AstraZeneca PLC, Company Share (%),China Drug Delivery Devices Market, 2010 89

Figure 48: Boehringer Ingelheim GmbH, Company Share (%),China Drug Delivery Devices Market, 2010 90

Figure 49: Sunovion, Company Share (%),China Drug Delivery Devices Market, 2010 91

Figure 50: Fresenius Kabi AG, Company Share (%),China Drug Delivery Devices Market, 2010 92

Companies Mentioned

GlaxoSmithKline plc

AstraZeneca PLC

Boehringer Ingelheim GmbH

Sunovion

Fresenius Kabi AG

3M Health Care

Baxter International Inc.

Terumo Corporation

Teleflex Incorporated

Hospira, Inc.

Medtronic, Inc.

Consort Medical plc

Smiths Medical

JMS CO., LTD.

CareFusion Corporation

NIPRO CORPORATION

B. Braun Melsungen AG

Edwards Lifesciences Corporation

INJEX - Equidyne Systems

Bioject Medical Technologies Inc.

To order this report:

Drug Delivery Technology Industry: Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Drug Delivery Technology Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

CONTACT:  
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: +1-805-652-2626
Intl: +1-805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 11, 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ... the lives of pets, today announced the submission to ... Animal Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  ... of Zimeta for the control of pyrexia (fever) in ... --> --> The Chemistry, Manufacturing, ...
(Date:2/11/2016)... FRANCISCO , Feb. 11, 2016   Health ... advancement of new health technologies, announced today " 10 ... achievements in health tech over the past ten years.   ... For nearly a decade, Health 2.0 has served as ... showcased and connected with thousands of technologies, companies, innovators, ...
(Date:2/11/2016)... Feb. 11, 2016  MiMedx Group, Inc. (NASDAQ: ... amniotic membrane and other birth tissues, human skin and ... and market advanced products and therapies, announced today that ... Global Healthcare Conference in New York ... Michael J. Senken , Chief Financial Officer and ...
Breaking Medicine Technology:
(Date:2/12/2016)... York, NY (PRWEB) , ... February 12, 2016 ... ... edition of “Revolutionizing Cancer Care.” , The print component of “Revolutionizing ... Chicago, Dallas, Pittsburgh/Cleveland, New York, Washington DC/Baltimore, and Seattle, with a circulation of ...
(Date:2/12/2016)... ... February 12, 2016 , ... Atlantic Information Services, Inc. ... and PBMs,” an upcoming Feb. 24 webinar that will discuss ways health plans ... categories, such as the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost PCSK9 inhibitors ...
(Date:2/12/2016)... ... ... US Sport Camps is pleased to announce the addition of junior golf ... the host site and directing the camps is PGA Professional and 2008 Iowa State ... recent years around Des Moines and are fortunate to have such a well-respected instructor ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Healthcare careers ... the five most searched jobs via the website of healthcare staffing leader Aureus Medical ... travel nurse jobs , travel therapy positions and in travel and ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... growth in the field of long term care. With that, says Patrick Loughney, ... healthcare professionals in administrative roles in long term care environments. His company, which ...
Breaking Medicine News(10 mins):